Welby Inc. (TYO:4438)

Market Cap	2.55B +1.4%
Revenue (ttm)	724.00M +14.9%
Net Income	-519.00M
EPS	-62.31
Shares Out	8.54M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,600
Open	298.00
Previous Close	303.00
Day's Range	296.00 - 305.00
52-Week Range	231.00 - 558.00
Beta	1.17
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Welby

Welby Inc. engages in the provision of digital health solutions that help patients to get medical care services in Japan. The company provides services in the areas of diabetes, lifestyle-related disease, autoimmune disease, rare disease, oncology, and blood disorders. It also engages in the medical data research business; and operates apps, web services, and data management. Welby Inc. was incorporated in 2011 and is headquartered in Chuo, Japan.

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2011
• Employees: 44
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4438

Financial Performance

In 2025, Welby's revenue was 635.00 million, an increase of 20.27% compared to the previous year's 528.00 million. Losses were -539.00 million, -32.96% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 26, 2026

Data Sources Report a data error